Costlier AMD Prescriptions Linked to Manufacturer Payments to Ophthalmologists
A cross-sectional analysis of Medicare Part B data spending shows ophthalmologists who received manufacturer funding were less likely to prescribe bevacizumab.
Source: hcplive.com